Cost-Effectiveness of a Clinical Childhood Obesity Intervention

Pediatrics
Mona SharifiElsie M Taveras

Abstract

To estimate the cost-effectiveness and population impact of the national implementation of the Study of Technology to Accelerate Research (STAR) intervention for childhood obesity. In the STAR cluster-randomized trial, 6- to 12-year-old children with obesity seen at pediatric practices with electronic health record (EHR)-based decision support for primary care providers and self-guided behavior-change support for parents had significantly smaller increases in BMI than children who received usual care. We used a microsimulation model of a national implementation of STAR from 2015 to 2025 among all pediatric primary care providers in the United States with fully functional EHRs to estimate cost, impact on obesity prevalence, and cost-effectiveness. The expected population reach of a 10-year national implementation is ∼2 million children, with intervention costs of $119 per child and $237 per BMI unit reduced. At 10 years, assuming maintenance of effect, the intervention is expected to avert 43 000 cases and 226 000 life-years with obesity at a net cost of $4085 per case and $774 per life-year with obesity averted. Limiting implementation to large practices and using higher estimates of EHR adoption improved both cost-effectivenes...Continue Reading

Associated Clinical Trials

References

Jan 23, 1999·Archives of Pediatrics & Adolescent Medicine·A B BocianR S Miller
Jul 3, 2004·Pediatrics·Edward L Schor
Sep 28, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M M HabyB Swinburn
Dec 13, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Z McCallumE Waters
Oct 12, 2007·The New England Journal of Medicine·Rita Mangione-SmithElizabeth A McGlynn
Dec 18, 2007·Pediatrics·Bonnie A SpearElsie M Taveras
Feb 1, 2008·American Journal of Public Health·Eric A Finkelstein, Justin G Trogdon
Sep 3, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A A GorinUNKNOWN Look AHEAD Home Environment Research Group
Jan 6, 2009·Pediatrics·Patrick H ConwayCarolyn Clancy
Jan 1, 2010·The New England Journal of Medicine·David Blumenthal
Jan 20, 2010·Pediatrics·UNKNOWN US Preventive Services Task Force, Mary Barton
Dec 1, 2008·Expert Review of Pharmacoeconomics & Outcomes Research·Rob CarterCathrine Mihalopoulos
Jan 29, 2011·Academic Pediatrics·Chuck NorlinMartin T Stein
Jun 15, 2011·American Journal of Preventive Medicine·Terry T-K HuangAshley Wilder Smith
Aug 30, 2011·Lancet·Kevin D HallBoyd A Swinburn
Dec 8, 2011·Archives of Pediatrics & Adolescent Medicine·Eliana M PerrinMichael J Steiner
Apr 21, 2012·American Journal of Preventive Medicine·Y Claire WangSteven L Gortmaker
Feb 5, 2013·Clinical Pediatrics·Mona SharifiElsie M Taveras
Dec 19, 2013·The Lancet. Diabetes & Endocrinology·Kevin D HallCarson C Chow
Jan 30, 2014·BMC Health Services Research·Davene R WrightLisa A Prosser
Mar 25, 2014·Childhood Obesity·Leonard H EpsteinEric Finkelstein
Dec 31, 2014·Pediatrics·Christoph U LehmannTimothy D Johnson
Sep 14, 2016·Pediatrics·Leslie A SimM Hassan Murad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.